Frontier Medicines, based on UC Berkeley research, has launched with $67m in series A funding co-led by Deerfield Management, MPM Capital and Droia Oncology Ventures.

Lab10x will accelerate the commercialisation of digital therapeutics and data-driven drug discovery, and is being launched in partnership with Sensyne Health and Evotec.

Building on joint research from University of Vienna and Medical University of Vienna, P4 is creating next-generation platinum chemotherapy with fewer side-effects than current approaches.

Satt Sud-Est has assigned an exclusive licence to Arteac-Lab, co-founded by former CNRS researcher Philippe Herzog, for an electroacoustic modeling software called Simbox.

A collaborative research fund established by Imperial and TUM has made its public debut with at least 12 projects in its portfolio focused on areas including healthcare, energy and industry.

University at Buffalo has spun out Surgino to tackle the risk of hernias following surgical stitching, with a tool intended to improve measurements of tension in the stitched tissues.

The "Spin-Off Universität St. Gallen" label has been granted to 122 spinouts over the past two years, with 22 of those remaining based in the city.

Clean Earth Tech will commercialise a dust suppressant polymer invented by Minkyu Kim at UA's College of Engineering.

Erganeo is the new moniker for regional tech transfer office Satt IDF Innov, which has invested $30.5m over the past seven years and is adopting an increasingly deep tech-led focus.

French regional TTOs Satt Conectus, Satt Nord and Satt Sayens hope to source skilled business leaders and management for their pipeline of deep tech spinouts.